Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 USD | -0.61% |
|
+19.85% | -39.07% |
Jul. 01 | Harvard Bioscience, Inc.(NasdaqGM:HBIO) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Harvard Bioscience, Inc.(NasdaqGM:HBIO) added to Russell 3000E Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.07% | 142M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- HBIO Stock
- News Harvard Bioscience, Inc.
- Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth